The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Keynote 290: Pembrolizumab (pem) in combination with stereotactic body radiotherapy for resectable liver metastatic colorectal cancer.
 
Dustin A. Deming
Consulting or Advisory Role - Novocure
Research Funding - Merck
 
David H. Kim
No Relationships to Disclose
 
Kristina Matkowskyj
No Relationships to Disclose
 
Nataliya Volodymyrivna Uboha
No Relationships to Disclose
 
Sam Joseph Lubner
No Relationships to Disclose
 
Noelle K. LoConte
Consulting or Advisory Role - Celgene
 
Daniel Mulkerin
No Relationships to Disclose
 
Daniel Abbott
No Relationships to Disclose
 
Sharon M. Weber
No Relationships to Disclose
 
Emily Winslow
No Relationships to Disclose
 
Robert Jeraj
Stock and Other Ownership Interests - AIQ Solutions
Research Funding - GE Healthcare
Patents, Royalties, Other Intellectual Property - Several Wisconsin Alumni Research Foundation patents
 
Mark A. Ritter
No Relationships to Disclose
 
Scott Perlman
No Relationships to Disclose
 
Jens C. Eickhoff
Research Funding - Sanofi Pasteur (Inst)
 
Michael Frederick Bassetti
No Relationships to Disclose